<?xml version="1.0" encoding="UTF-8"?>
<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the coronavirus family responsible for the 2019 pandemic coronavirus disease 19 (COVID-19), which was first identified in Wuhan, China in December 2019.
 <xref rid="cit0001" ref-type="bibr">1</xref>,
 <xref rid="cit0002" ref-type="bibr">2</xref> According to a recent World Health Organizationreport (May 28, 2020), COVID-19 had been confirmed in 216 countries, with more than 5.5 million positive cases and over 350,000 confirmed deaths.
 <xref rid="cit0003" ref-type="bibr">3</xref> This global health crisis created by COVID-19 is of serious concern to rheumatologists. Rheumatic diseases compromise patient immunity, and the use of immunosuppressant drugs further compounds this effect.
 <xref rid="cit0004" ref-type="bibr">4</xref> After the first report of SARS-CoV-2 infection from Nepal in a student who returned from Wuhan,
 <xref rid="cit0005" ref-type="bibr">5</xref> there has been a rapid implementation of countrywide lockdown and various awareness programs on social media.
 <xref rid="cit0006" ref-type="bibr">6</xref>
</p>
